Literature DB >> 1584779

Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.

J A Piedrahita1, S H Zhang, J R Hagaman, P M Oliver, N Maeda.   

Abstract

We have inactivated the endogenous apolipoprotein E (apoE) gene by using gene targeting in mouse embryonic stem (ES) cells. Two targeting plasmids were used, pJPB63 and pNMC109, both containing a neomycin-resistance gene that replaces a part of the apoE gene and disrupts its structure. ES cell colonies targeted after electroporation with plasmid pJPB63 were identified by the polymerase chain reaction (PCR) followed by genomic Southern analysis. Of 648 G418-resistant colonies analyzed, 9 gave a positive signal after PCR amplification, and 5 of them were confirmed as targeted by Southern blot analysis. The second plasmid, pNMC109, contains the negatively selectable thymidine kinase gene in addition to the neomycin-resistance gene. After electroporation with this plasmid, 177 colonies resistant both to G418 and ganciclovir were analyzed; 39 contained a disrupted apoE gene as determined by Southern blotting. Chimeric mice were generated by blastocyst injection with 6 of the targeted lines. One of the lines gave strong chimeras, three of which transmitted the disrupted apoE gene to their progeny. Mice homozygous for the disrupted gene were produced from the heterozygotes; they appear healthy, even though they have no apolipoprotein E in their plasma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584779      PMCID: PMC49104          DOI: 10.1073/pnas.89.10.4471

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.

Authors:  K R Thomas; M R Capecchi
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

2.  Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells.

Authors:  P Hasty; J Rivera-Pérez; C Chang; A Bradley
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

3.  Diffusion-in-gel methods for immunological analysis. II.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1962

4.  Structure and expression of mouse apolipoprotein E gene.

Authors:  K Horiuchi; S Tajima; M Menju; A Yamamoto
Journal:  J Biochem       Date:  1989-07       Impact factor: 3.387

5.  The molecular basis of atherosclerosis: concepts derived from studies of lipoprotein metabolism and cell biology.

Authors:  R W Mahley
Journal:  Clin Invest Med       Date:  1986-11       Impact factor: 0.825

6.  Recombinant fragment assay for gene targetting based on the polymerase chain reaction.

Authors:  H S Kim; O Smithies
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

Review 7.  Genetics of coronary heart disease.

Authors:  K Berg
Journal:  Prog Med Genet       Date:  1983

8.  Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice.

Authors:  B Paigen; D Mitchell; K Reue; A Morrow; A J Lusis; R C LeBoeuf
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Apolipoprotein E deficiency with a depressed mRNA of normal size.

Authors:  D Kurosaka; T Teramoto; T Matsushima; T Yokoyama; A Yamada; T Aikawa; Y Miyamoto; K Kurokawa
Journal:  Atherosclerosis       Date:  1991-05       Impact factor: 5.162

Review 10.  Apolipoprotein genetic variation and human disease.

Authors:  J L Breslow
Journal:  Physiol Rev       Date:  1988-01       Impact factor: 37.312

View more
  287 in total

1.  Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

Authors:  M Buttini; M Orth; S Bellosta; H Akeefe; R E Pitas; T Wyss-Coray; L Mucke; R W Mahley
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Factors affecting the efficiency of introducing precise genetic changes in ES cells by homologous recombination: tag-and-exchange versus the Cre-loxp system.

Authors:  J C Vazquez; C Nogues; E B Rucker; J A Piedrahita
Journal:  Transgenic Res       Date:  1998-05       Impact factor: 2.788

3.  Aspirin resistance with genetic dyslipidemia: contribution of vascular thromboxane generation.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Phoebe A Stapleton; Stephanie J Frisbee; Alexandre C d'Audiffret
Journal:  Physiol Genomics       Date:  2010-06-08       Impact factor: 3.107

4.  Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E.

Authors:  Y Terasawa; Z Ladha; S W Leonard; J D Morrow; D Newland; D Sanan; L Packer; M G Traber; R V Farese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.

Authors:  J H Qiao; J Tripathi; N K Mishra; Y Cai; S Tripathi; X P Wang; S Imes; M C Fishbein; S K Clinton; P Libby; A J Lusis; T B Rajavashisth
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

6.  Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.

Authors:  M Watanabe; J Osada; Y Aratani; K Kluckman; R Reddick; M R Malinow; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.

Authors:  Masanori Ozaki; Seinosuke Kawashima; Tomoya Yamashita; Tetsuaki Hirase; Masayuki Namiki; Nobutaka Inoue; Ken-ichi Hirata; Hiroyuki Yasui; Hiromu Sakurai; Yuichi Yoshida; Masahiro Masada; Mitsuhiro Yokoyama
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.

Authors:  V E Laubach; E G Shesely; O Smithies; P A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Phage-display-guided nanocarrier targeting to atheroprone vasculature.

Authors:  Lucas H Hofmeister; Sue Hyun Lee; Allison E Norlander; Kim Ramil C Montaniel; Wei Chen; David G Harrison; Hak-Joon Sung
Journal:  ACS Nano       Date:  2015-03-23       Impact factor: 15.881

10.  Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.

Authors:  A Nicoletti; S Kaveri; G Caligiuri; J Bariéty; G K Hansson
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.